市場調査レポート

商品コード

1747498

うっ血性心不全市場：タイプ別、診断別、性別、年齢層別、エンドユーザー別、地域別

Congestive Heart Failure Market, By Type, By Diagnosis, By Gender, By Age Group, By End User, By Geography

出版日: 2025年05月14日
発行: Coherent Market Insights
ページ情報: 英文 140 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 658,620円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,024,520円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,463,600円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.36円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界のうっ血性心不全市場は、2025年に249億5,000万米ドルと推定され、2032年には408億5,000万米ドルに達すると予測され、2025年から2032年までのCAGRは7.3%で成長する見込みです。

レポート範囲		レポート詳細
基準年	2024	2025年の市場規模	249億5,000万米ドル
実績データ	2020年から2024年まで	予測期間	2025年から2032年
予測期間：2025年～2032年 CAGR：	7.30%	2032年の価値予測	408億5,000万米ドル

世界のうっ血性心不全市場は、心血管疾患の有病率の増加、高齢者人口の増加、効果的な治療オプションに対する需要の高まりなどを背景に、近年著しい成長を遂げています。うっ血性心不全（CHF）は、心臓が体の必要量を満たすのに十分な血液を送り出せないことを特徴とする慢性疾患です。高度な診断技術と革新的な治療アプローチの出現により、CHF管理市場は大幅に拡大しています。

市場力学：.

世界のうっ血性心不全市場は、心血管疾患の有病率の上昇、高齢者人口の増加、座りがちなライフスタイルの増加など、いくつかの要因によって牽引されています。また、うっ血性心不全の早期診断と治療の重要性に対する認識が高まっていることも、市場の成長に寄与しています。しかし、治療費が高く、償還政策が不十分な地域もあるため、市場成長が抑制される可能性があります。さらに、利用可能な治療オプションの一部に関連する副作用も市場成長の妨げとなる可能性があります。一方、遺伝子治療や幹細胞治療などの新規治療法の開発や個別化医療への注目の高まりは、市場関係者に大きな成長機会を提供しています。また、新規治療開発のための製薬企業と研究機関との共同研究の増加も、今後数年間の市場開拓を促進すると予想されます。

本調査の主な特徴

当レポートでは、世界のうっ血性心不全市場を詳細に分析し、2024年を基準年とした予測期間（2025年～2032年）の市場規模（10億米ドル）および複合年間成長率（CAGR%）を掲載しています。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界のうっ血性心不全市場における主要企業プロファイルを掲載しています。
このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
世界のうっ血性心不全市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
利害関係者は、世界のうっ血性心不全市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 24.95 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.30%	2032 Value Projection:	USD 40.85 Bn

The global congestive heart failure market has witnessed significant growth in recent years, driven by the increasing prevalence of cardiovascular diseases, the rising geriatric population, and the growing demand for effective treatment options. Congestive heart failure (CHF) is a chronic condition characterized by the heart's inability to pump sufficient blood to meet the body's needs. With the advent of advanced diagnostic techniques and innovative treatment approaches, the market for CHF management has expanded considerably.

Market Dynamic:

The global congestive heart failure market is driven by several factors, including the rising prevalence of cardiovascular diseases, the growing geriatric population, and the increasing adoption of sedentary lifestyles. The increasing awareness about the importance of early diagnosis and treatment of CHF have also contributed to the market growth. However, the high cost of treatment and the lack of reimbursement policies in some regions may restrain the market growth. Moreover, the side effects associated with some of the available treatment options may also hinder the market growth. On the other hand, the development of novel therapies, such as gene therapy and stem cell therapy, and the increasing focus on personalized medicine offer significant growth opportunities for the market players. Increasing collaborations between pharmaceutical companies and research institutes for the development of novel therapies are also expected to drive the market growth in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global congestive heart failure market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global congestive heart failure market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Novartis, Boehringer Ingelheim, AstraZeneca, Johnson & Johnson, Abbott, Medtronic, Boston Scientific, Pfizer, Merck & Co, Bristol Myers Squibb, LivaNova, Biotronik, V-Wave, Impulse Dynamics, and CVRx
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global congestive heart failure market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global congestive heart failure market

Market Segmentation

Type Insights (Revenue, USD Bn, 2020 - 2032)
- Systolic Heart Failure
- Diastolic Heart Failure
- Acute Heart Failure
- Chronic Heart Failure
Diagnosis Insights (Revenue, USD Bn, 2020 - 2032)
- Echocardiography
- Chest X-Ray
- Blood Tests (BNP, NT-proBNP)
- Cardiac Catheterization
- Magnetic Resonance Imaging
- Holter Monitoring
- Nuclear Imaging
Device Type Insights (Revenue, USD Bn, 2020 - 2032)
- Pacemakers
- Implantable Cardioverter-Defibrillators (ICDs)
- Cardiac Resynchronization Therapy (CRT) Devices
- Ventricular Assist Devices (VADs)
- Remote Monitoring Devices
- Others
Gender Insights (Revenue, USD Bn, 2020 - 2032)
- Male
- Female
Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Adult
- Pediatrics
- Geriatric
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
- Home Healthcare
- Academic and Research Institutes
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Novartis
- Boehringer Ingelheim
- AstraZeneca
- Johnson & Johnson
- Abbott
- Medtronic
- Boston Scientific
- Pfizer
- Merck & Co
- Bristol Myers Squibb
- LivaNova
- Biotronik
- V-Wave
- Impulse Dynamics
- CVRx

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Congestive Heart Failure Market, By Type
- Global Congestive Heart Failure Market, By Diagnosis
- Global Congestive Heart Failure Market, By Device Type
- Global Congestive Heart Failure Market, By Gender
- Global Congestive Heart Failure Market, By Age Group
- Global Congestive Heart Failure Market, By End User
- Global Congestive Heart Failure Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Congestive Heart Failure Market, By Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Systolic Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diastolic Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Acute Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chronic Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Congestive Heart Failure Market, By Diagnosis, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Echocardiography
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chest X-Ray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Blood Tests (BNP, NT-proBNP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiac Catheterization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Magnetic Resonance Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Holter Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Nuclear Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Congestive Heart Failure Market, By Device Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pacemakers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Implantable Cardioverter-Defibrillators (ICDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiac Resynchronization Therapy (CRT) Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ventricular Assist Devices (VADs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Remote Monitoring Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Congestive Heart Failure Market, By Gender, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Congestive Heart Failure Market, By Age Group, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Congestive Heart Failure Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Home Healthcare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Congestive Heart Failure Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

Novartis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boston Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
LivaNova
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biotronik
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
V-Wave
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Impulse Dynamics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CVRx
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

12. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

13. References and Research Methodology

References
Research Methodology
About us

うっ血性心不全市場：タイプ別、診断別、性別、年齢層別、エンドユーザー別、地域別

Congestive Heart Failure Market, By Type, By Diagnosis, By Gender, By Age Group, By End User, By Geography

本調査の主な特徴

目次

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界のうっ血性心不全市場、タイプ別、2020年～2032年

第5章世界のうっ血性心不全市場、診断別、2020年～2032年

第6章世界のうっ血性心不全市場、デバイスタイプ別、2020年～2032年

第7章世界のうっ血性心不全市場、性別、2020年～2032年

第8章世界のうっ血性心不全市場、年齢層別、2020年～2032年

第9章世界のうっ血性心不全市場、エンドユーザー別、2020年～2032年

第10章世界のうっ血性心不全市場、地域別、2020年～2032年

第11章競合情勢

第12章アナリストの推奨事項

第13章参考文献と調査手法

Key Features of the Study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Congestive Heart Failure Market, By Type, 2020-2032, (USD Bn)

5. Global Congestive Heart Failure Market, By Diagnosis, 2020-2032, (USD Bn)

6. Global Congestive Heart Failure Market, By Device Type, 2020-2032, (USD Bn)

7. Global Congestive Heart Failure Market, By Gender, 2020-2032, (USD Bn)

8. Global Congestive Heart Failure Market, By Age Group, 2020-2032, (USD Bn)

9. Global Congestive Heart Failure Market, By End User, 2020-2032, (USD Bn)

10. Global Congestive Heart Failure Market, By Region, 2020 - 2032, Value (USD Bn)

11. Competitive Landscape

12. Analyst Recommendations

13. References and Research Methodology

うっ血性心不全市場：タイプ別、診断別、性別、年齢層別、エンドユーザー別、地域別

Congestive Heart Failure Market, By Type, By Diagnosis, By Gender, By Age Group, By End User, By Geography

本調査の主な特徴

目次

第1章 調査の目的と前提条件

第2章 市場の展望

第3章 市場力学、規制、動向分析

第4章 世界のうっ血性心不全市場、タイプ別、2020年～2032年

第5章 世界のうっ血性心不全市場、診断別、2020年～2032年

第6章 世界のうっ血性心不全市場、デバイスタイプ別、2020年～2032年

第7章 世界のうっ血性心不全市場、性別、2020年～2032年

第8章 世界のうっ血性心不全市場、年齢層別、2020年～2032年

第9章 世界のうっ血性心不全市場、エンドユーザー別、2020年～2032年

第10章 世界のうっ血性心不全市場、地域別、2020年～2032年

第11章 競合情勢

第12章 アナリストの推奨事項

第13章 参考文献と調査手法

Key Features of the Study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Congestive Heart Failure Market, By Type, 2020-2032, (USD Bn)

5. Global Congestive Heart Failure Market, By Diagnosis, 2020-2032, (USD Bn)

6. Global Congestive Heart Failure Market, By Device Type, 2020-2032, (USD Bn)

7. Global Congestive Heart Failure Market, By Gender, 2020-2032, (USD Bn)

8. Global Congestive Heart Failure Market, By Age Group, 2020-2032, (USD Bn)

9. Global Congestive Heart Failure Market, By End User, 2020-2032, (USD Bn)

10. Global Congestive Heart Failure Market, By Region, 2020 - 2032, Value (USD Bn)

11. Competitive Landscape

12. Analyst Recommendations

13. References and Research Methodology

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界のうっ血性心不全市場、タイプ別、2020年～2032年

第5章世界のうっ血性心不全市場、診断別、2020年～2032年

第6章世界のうっ血性心不全市場、デバイスタイプ別、2020年～2032年

第7章世界のうっ血性心不全市場、性別、2020年～2032年

第8章世界のうっ血性心不全市場、年齢層別、2020年～2032年

第9章世界のうっ血性心不全市場、エンドユーザー別、2020年～2032年

第10章世界のうっ血性心不全市場、地域別、2020年～2032年

第11章競合情勢

第12章アナリストの推奨事項

第13章参考文献と調査手法